Announcements Trials
Browse Landscape

Phase

Phase 2 338Phase 1 66Phase 1/2 58Phase 3 42Phase NA 16Phase 4 6Phase 2/3 5Phase EARLY_PHASE1 4

Status

Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Cetuximab × Clear all
NCT05816785 2026-04-22

Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

University of Wisconsin, Madison

Phase EARLY_PHASE1 Active not recruiting
15 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06011772 2026-03-11

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

Roswell Park Cancer Institute

Phase EARLY_PHASE1 Active not recruiting
2 enrolled
Gastrointestinal

Colonic Neoplasms

NCT07318389 2026-02-27

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Not yet recruiting
100 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00757549 2017-10-31

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Mayo Clinic

Phase EARLY_PHASE1 Completed
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡